Abbott CGM Death Reports Rise as MAUDE Flags New Device Issues

Maude Monthly: Abbott CGM Low Reading Problem Continues to Grow as Company Discloses Additional Death; Medline Reports Hundreds of Late Reports in Wake of FDA Scrutiny; MAUDE Data Reveals Additional Issue with Insulet Omnipod

The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports from users, physicians, and device manufacturers. The FDA uses MAUDE reports to monitor […]

Commerce Department’s National Security Watchdog Grants UAE Firm with History of Tech Transfers to China Access to Sensitive AI Chips Even as Agency Chief Says Enforcement Understaffed

The Commerce Department’s Bureau of Industry and Security (BIS) has issued a rule that grants G42, United Arab Emirates-controlled with alleged history of technology transfers to China,...

Jul 15, 2026 Read Now >

Health Care Weekly: HHS OIG Requests Information on Direct-To-Consumer Drug Sales, Anti-Kickback Laws; CMS Seeks to Break AMA Monopoly on Coding and Payments; CMS to Propose Rule Loosening Conditions for Participation in Medicare, Medicaid; FTC Settles With Caremark; FDA to Defend Legal Authority to Publish CRLs; FDA Cracks Down on Online Ketamine Sales; FDA Issues Guidance, Schedules Hearing on Psychedelic Research and Usage

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...

Jul 15, 2026 Read Now >

Senators Co-Sponsoring Legislation That Would Empower Qualcomm in IP Licensing Fight with Arm

Two U.S. senators are co-sponsoring legislation that would require foreign companies such as Arm Holdings (ARM) to license technology vital for making semiconductors to customers like Qualcomm (QCOM)...

Jul 15, 2026 Read Now >

Maude Monthly: Abbott CGM Low Reading Problem Continues to Grow as Company Discloses Additional Death; Medline Reports Hundreds of Late Reports in Wake of FDA Scrutiny; MAUDE Data Reveals Additional Issue with Insulet Omnipod

RELATED ARTICLES | Corporate investigations

Commerce Department’s National Security Watchdog Grants UAE Firm with History of Tech Transfers to China Access to Sensitive AI Chips Even as Agency Chief Says Enforcement Understaffed

Senators Co-Sponsoring Legislation That Would Empower Qualcomm in IP Licensing Fight with Arm

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.